Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Effective Management of CINV Improves Response to Treatment

January 26th 2018

The goal of selecting optimal antiemetic therapy continues to be a moving target with the emergence of newer agents and patient-related risk factors, as well as the rapid evolution of guidelines for the management of chemotherapy-induced nausea and vomiting.

Looking to the Future of Myeloma Care

January 23rd 2018

Improving Outcomes in Myeloma

January 23rd 2018

Immunotherapies in Myeloma

January 23rd 2018

Other Agents for Treating Myeloma

January 23rd 2018

Impact of MRD Assessment on Myeloma Treatment

January 23rd 2018

The Role of MRD Testing in Myeloma

January 23rd 2018

Adding Carfilzomib to R/R Myeloma Regimens

January 23rd 2018

Impact of Elotuzumab in R/R Myeloma Therapies

January 23rd 2018

Daratumumab-Based Regimens in R/R Myeloma

January 23rd 2018

The Role of Transplant in Myeloma

January 23rd 2018

Impact of Maintenance Therapy in Myeloma

January 23rd 2018

Upfront Combination Therapies in Myeloma

January 23rd 2018

Upfront Therapy Approaches in Myeloma

January 23rd 2018

Managing High-Risk Smoldering Myeloma

January 23rd 2018

Risk Assessment for Myeloma

January 23rd 2018

Experts Reflect on Oncology Advancements in 2017

December 29th 2017

Key opinion leaders share the biggest advancements in oncology made this past year.

Experts Discuss Ways to Remove Barriers to Optimal Management of CINV

December 26th 2017

Despite the widespread availability of antiemetic regimens, between 30% and 50% of patients receiving chemotherapy experience treatment-related nausea and/or vomiting.

Unmet Needs in Ovarian Cancer

December 23rd 2017

Evolving Role of PARP Inhibitors in Ovarian Cancer

December 23rd 2017

x